abstract |
The present invention relates to a method for suppressing cancer, characterized by activating a p53 tumor suppressor gene or p53 protein and localizing it to the nucleus, and a pharmaceutical composition comprising a substance that promotes the activity of the p53 tumor suppressor gene or p53 protein Offer things. |